» Articles » PMID: 33221431

Universal PCR Screening for Coronavirus Disease 2019 in Asymptomatic Patients on Admission

Overview
Publisher Elsevier
Date 2020 Nov 22
PMID 33221431
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Cost-Effectiveness of Universal Asymptomatic Preoperative SARS-CoV-2 Polymerase Chain Reaction Screening: A Cost-Utility Analysis.

Uno S, Goto R, Honda K, Uchida S, Uwamino Y, Namkoong H Clin Infect Dis. 2023; 78(1):57-64.

PMID: 37556365 PMC: 10810706. DOI: 10.1093/cid/ciad463.


Coronavirus disease 2019 (COVID-19) universal admission screening in patients and companions in Taiwan from May 2021 to June 2022: A nationwide multicenter study.

Wu H, Su C, Chien L, Tseng S, Chang S Infect Control Hosp Epidemiol. 2023; 45(1):68-74.

PMID: 37462097 PMC: 10782195. DOI: 10.1017/ice.2023.144.


DNA amplification tests at universal pre-admission screening with enhanced precaution strategies for asymptomatic patients with COVID-19.

Nakamura I, Watanabe Y, Fujita H, Kobayashi T, Watanabe H, Itoi T IJID Reg. 2023; 7:6-10.

PMID: 36618878 PMC: 9803604. DOI: 10.1016/j.ijregi.2022.12.010.


Universal admission screening for COVID-19 using quantitative antigen testing and questionnaire screening to prevent nosocomial spread.

Morishima M, Kimura M, Sakoh T, Yamamuro R, Ogura S, Takahashi N PLoS One. 2022; 17(11):e0277426.

PMID: 36355849 PMC: 9648767. DOI: 10.1371/journal.pone.0277426.


Clinical characteristics of patients with asymptomatic and symptomatic COVID-19 admitted to a tertiary referral centre in the Philippines.

Malundo A, Abad C, Salamat M, Sandejas J, Planta J, Poblete J IJID Reg. 2022; 2:204-211.

PMID: 35721425 PMC: 8818128. DOI: 10.1016/j.ijregi.2022.02.002.


References
1.
Poljak M, Korva M, Knap Gasper N, Fujs Komlos K, Sagadin M, Ursic T . Clinical Evaluation of the cobas SARS-CoV-2 Test and a Diagnostic Platform Switch during 48 Hours in the Midst of the COVID-19 Pandemic. J Clin Microbiol. 2020; 58(6). PMC: 7269406. DOI: 10.1128/JCM.00599-20. View